Feb 09, 2016 13:00 pm UTC| Business
UNIONDALE, N.Y., Feb. 09, 2016 -- Flushing Financial Corporation (the “Company”) (Nasdaq:FFIC), the parent holding company for Flushing Bank (the “Bank”), today announced that John R. Buran, the Company’s President and...
Cummins Announces $500 Million Accelerated Share Repurchase
Feb 09, 2016 12:34 pm UTC| Business
COLUMBUS, Ind., Feb. 9, 2016 -- Cummins Inc. (NYSE: CMI) today announced that it has entered into an accelerated share repurchase (ASR) agreement with Goldman, Sachs Co. (GS Co.) to repurchase $500 million of Cummins'...
Vishay Reports Results for Fourth Quarter and Year 2015
Feb 09, 2016 12:30 pm UTC| Business
Revenues for Q4 2015 of $556 million and for year 2015 of $2,300 millionOperating Margin Q4 of 5.4% and year 2015 of 4.3%Adjusted Operating Margin Q4 of 7.2% and year 2015 of 7.8%EPS Q4 of $(0.93) and year 2015 of...
Liberty Property Trust Announces Fourth Quarter and Full Year Results
Feb 09, 2016 12:30 pm UTC| Business
Fourth quarter highlights include: Funds from Operations $0.65 per share2.5 million square feet of non-core, suburban office and flex properties sold for $265 million$75 million in developments delivered at a yield of...
Lincoln Electric Announces New Organizational and Segment Reporting Structure
Feb 09, 2016 12:30 pm UTC| Business
CLEVELAND, Feb. 09, 2016 -- Lincoln Electric Holdings Inc., (“Lincoln Electric,” the “Company”) (Nasdaq:LECO) today announced that it has realigned its organizational and leadership structure to drive greater...
Alliqua BioMedical, Inc. to Announce Fourth Quarter and Fiscal Year 2015 Results on February 23rd
Feb 09, 2016 12:30 pm UTC| Business
LANGHORNE, Pa., Feb. 09, 2016 -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announced plans to release fourth quarter and fiscal year 2015...
Amicus Therapeutics Strengthens Executive Leadership Team
Feb 09, 2016 12:30 pm UTC| Business
CRANBURY, N.J., Feb. 09, 2016 -- Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront of therapies for rare and orphan diseases, has strengthened its executive leadership with the addition of two...